95 related articles for article (PubMed ID: 8900688)
1. Mycophenolate mofetil.
Bell J; Ross K
ANNA J; 1996 Aug; 23(4):409-10, 413. PubMed ID: 8900688
[No Abstract] [Full Text] [Related]
2. Therapeutic monitoring of mycophenolate mofetil.
Jeong H; Kaplan B
Clin J Am Soc Nephrol; 2007 Jan; 2(1):184-91. PubMed ID: 17699403
[No Abstract] [Full Text] [Related]
3. [A new immunosuppressor: CellCept].
Mouly-Bandini A
Presse Med; 2001 Jan; 30(2):66-7. PubMed ID: 11244816
[No Abstract] [Full Text] [Related]
4. Mycophenolate mofetil (CellCept): immunosuppression on the cutting edge.
Siconolfi L
AACN Clin Issues; 1996 Aug; 7(3):390-402. PubMed ID: 8826401
[TBL] [Abstract][Full Text] [Related]
5. Mycophenolate mofetil monitoring: is there evidence that it can improve outcomes?
Byrne R; Yost SE; Kaplan B
Clin Pharmacol Ther; 2011 Aug; 90(2):204-6. PubMed ID: 21772295
[No Abstract] [Full Text] [Related]
6. Mycophenolate mofetil.
Sievers TM; Rossi SJ; Ghobrial RM; Arriola E; Nishimura P; Kawano M; Holt CD
Pharmacotherapy; 1997; 17(6):1178-97. PubMed ID: 9399601
[TBL] [Abstract][Full Text] [Related]
7. Mycophenolate mofetil: a decade of clinical experience.
Danovitch GM
Transplantation; 2005 Oct; 80(2 Suppl):S272-4. PubMed ID: 16251860
[No Abstract] [Full Text] [Related]
8. Mycophenolate mofetil as induction therapy after liver transplantation.
McDiarmid SV
Liver Transpl Surg; 1999 Jul; 5(4 Suppl 1):S85-9. PubMed ID: 10431021
[No Abstract] [Full Text] [Related]
9. Mycophenolate mofetil--a new immunosuppressant for organ transplantation.
Med Lett Drugs Ther; 1995 Sep; 37(958):84-6. PubMed ID: 7674993
[No Abstract] [Full Text] [Related]
10. Treatment of recurrent heart rejection with mycophenolate mofetil (RS-61443): initial clinical experience.
Kirklin JK; Bourge RC; Naftel DC; Morrow WR; Deierhoi MH; Kauffman RS; White-Williams C; Nomberg RI; Holman WL; Smith DC
J Heart Lung Transplant; 1994; 13(3):444-50. PubMed ID: 8061021
[TBL] [Abstract][Full Text] [Related]
11. The incidence of subsequent acute rejection following the treatment of refractory renal allograft rejection with mycophenolate mofetil (RS61443).
Laskow DA; Deierhoi MH; Hudson SL; Orr CL; Curtis JJ; Diethelm AG
Transplantation; 1994 Feb; 57(4):640-3. PubMed ID: 8116055
[No Abstract] [Full Text] [Related]
12. Cytokine analysis before and after mycophenolate mofetil treatment in renal transplantation.
Oliveira JG; Sampaio S; Xavier P; Aragão P; Mendes A; Guerra L
Transplant Proc; 2000 Dec; 32(8):2631-2. PubMed ID: 11134732
[No Abstract] [Full Text] [Related]
13. The current status of mycophenolate mofetil in pediatric renal transplantation.
Tönshoff B
Pediatr Transplant; 1999 Feb; 3(1):5-9. PubMed ID: 10359025
[No Abstract] [Full Text] [Related]
14. Mycophenolate-update after it has come of age.
Grinyó JM
Nephrol Dial Transplant; 1999 Jan; 14(1):31-4. PubMed ID: 10052471
[No Abstract] [Full Text] [Related]
15. A review of clinical experience with the novel immunosuppressive drug mycophenolate mofetil in renal transplantation.
Behrend M
Clin Nephrol; 1996 May; 45(5):336-41. PubMed ID: 8738667
[TBL] [Abstract][Full Text] [Related]
16. Mycophenolate mofetil monotherapy significantly decreases the immune response of acute rejection in rat liver allografts.
Martelius T; Lautenschlager I; Mäkisalo H; Höckerstedt K
Transplant Proc; 1997 Nov; 29(7):3153-4. PubMed ID: 9365705
[No Abstract] [Full Text] [Related]
17. Mechanisms of action of mycophenolate mofetil in preventing chronic rejection.
Allison AC
Transplant Proc; 2002 Nov; 34(7):2863-6. PubMed ID: 12431636
[No Abstract] [Full Text] [Related]
18. Therapeutic drug monitoring of mycophenolates: why make simple things complicated?
Kuypers DR; van Gelder T
Transplant Rev (Orlando); 2011 Apr; 25(2):45-6. PubMed ID: 21477747
[No Abstract] [Full Text] [Related]
19. [2/3 The antimetabolites (azathioprine and mycophenolate)].
Rave M; Limat S; Woronoff-Lemsi MC
Soins; 2007; (717):57-8. PubMed ID: 17877258
[No Abstract] [Full Text] [Related]
20. Current issues in therapeutic drug monitoring of mycophenolic acid: report of a roundtable discussion.
Shaw LM; Holt DW; Oellerich M; Meiser B; van Gelder T
Ther Drug Monit; 2001 Aug; 23(4):305-15. PubMed ID: 11477311
[No Abstract] [Full Text] [Related]
[Next] [New Search]
